CONDITIONS

The best defense against disease is early detection

Summers Anti-Aging Center screens for thousands of medical conditions and diseases to give you piece of mind about your health.  

39% of men and women will be diagnosed with cancer at some point during their lifetime

Explore common conditions

Alzheimer’s Disease
Melanoma Skin Cancer
Esophageal Cancer
Cervical Cancer
Uterine Cancer
Ovarian Cancer
Bladder Cancer
Liver Cancer
Brain Cancer
Stomach Cancer
Testicular Cancer
Non-Hodgkin's Lymphoma
Kidney Cancer
Larynx Cancer
Gallbladder Cancer
Colorectal Cancer
Prostate Cancer
Thyroid Cancer
Breast Cancer
Pancreatic Cancer
Lung Cancer
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Search 
x
 conditions
Alzheimer’s Disease

Alzheimer’s Disease

routine screening available
routine screening unavailable
screening not very effective
early symptoms
routine screening effective
no early symptoms
some early symptoms
LIFETIME PROBABILITY

15%

avg. stage of diagnosis

avg. five year survival
symptoms
  • Memory loss
  • Cognitive decline
  • Changes in behavior

Method of diagnosis
  • Whole-body MRI
  • Blood test
  • Neurological and functional assessment

IMPORTANT FACTS
  • 40-65% of people diagnosed with Alzheimer's have the APOE-e4 gene
  • Lifetime risk is roughly twice as high in women as in men
  • Alzheiemer’s contributes to 60-70% of dementia cases

WHY WE SCREEN

Summers uses several methods to support a diagnosis of Alzheimer’s disease, including a whole-body MRI to image and blood test to image amyloid plaques in the brain and a blood test to measure levels of beta-amyloid, a protein that accumulates abnormally in the brains of people with Alzheimer’s.

Melanoma Skin Cancer

Melanoma Skin Cancer

routine screening available
routine screening unavailable
screening not very effective
early symptoms
routine screening effective
no early symptoms
some early symptoms
LIFETIME PROBABILITY

2.2%

avg. stage of diagnosis

2

avg. five year survival
  • Stage I: 99%
  • Stage IV: 32% 
  • All stages: 94%

symptoms
  • Changes in moles or skin lesions 
  • Itching or tenderness
  • Bleeding or oozing

Method of diagnosis
  • Visual assessment 
  • AI skin cancer test

IMPORTANT FACTS
  • First warning signs are usually visual; patients rarely exhibit symptoms
  • Melanoma is the deadliest form of skin cancer but can be effectively treated when detected early.

WHY WE SCREEN

More than 90 percent of skin cancers are caused by sun exposure. Routine screening through our AI skin cancer test and visual assessment helps detect melanoma early before it has spread to distant parts of the body. Melanoma has an average 5 year survival of over 99 percent when caught in Stage I, demonstrating the importance of early detection.

Esophageal Cancer

Esophageal Cancer

routine screening available
routine screening unavailable
screening not very effective
early symptoms
routine screening effective
no early symptoms
some early symptoms
LIFETIME PROBABILITY

1%

avg. stage of diagnosis

3

avg. five year survival
  • Stage I: 47%
  • Stage IV: 4% 
  • All stages: 21%

symptoms
  • Difficulty swallowing 
  • Weight loss
  • Chronic heartburn or indigestion

Method of diagnosis
  • Whole-body MRI
  • Endoscopy

IMPORTANT FACTS
  • Sixth most common cause of cancer deaths worldwide
  • Adults aged 45 to 64 experienced a 100% increase in esophageal cancer cases between 2012 and 2019.
WHY WE SCREEN

Esophageal cancer is often considered a silent killer because it displays minimal symptoms until becoming advanced. The exact reason for the uptick in esophageal cancer is unknown, but higher rates of obesity, unhealthy diets, and chronic heartburn are likely factors. Endoscopy and MRI are both valuable tools in diagnosing esophageal cancer early.

Cervical Cancer

Cervical Cancer

routine screening available
routine screening unavailable
screening not very effective
early symptoms
routine screening effective
no early symptoms
some early symptoms
LIFETIME PROBABILITY

0.7%

avg. stage of diagnosis

1.5

avg. five year survival
  • Stage I: 92%
  • Stage IV: 16% 
  • All stages: 67%

symptoms
  • Abnormal Vaginal Bleeding
  • Pelvic Pain
  • Pain during sexual intercourse

Method of diagnosis
  • Pap smears 
  • HPV tests
  • Whole-body MRI

IMPORTANT FACTS
  • Preventable with HPV vaccination and regular screenings
  • Persistent infection with high-risk HPV is the primary cause
  • Pap smear and HPV tests starting at age 21 
WHY WE SCREEN

Even though a pap test is the gold standard for screening cervical cancer, a whole-body MRI can detect cervical cancer with high sensitivity and specificity. Routine screening for cervical cancer is important because patients typically experience no symptoms in the early stages.

Uterine Cancer

Uterine Cancer

routine screening available
routine screening unavailable
screening not very effective
early symptoms
routine screening effective
no early symptoms
some early symptoms
LIFETIME PROBABILITY

3%

avg. stage of diagnosis

1.5

avg. five year survival
  • Stage I: 95%
  • Stage IV: 17% 
  • All stages: 84%
symptoms
  • Abnormal Vaginal Bleeding
  • Pelvic Pain
  • Changes in Bladder or Bowel Habits

Method of diagnosis
  • Whole-body MRI
IMPORTANT FACTS
  • Type 1 progresses slowly, whereas Type 2 grows quickly
  • Sixth most common cancer in women globally

WHY WE SCREEN

Type 1 endometrial (uterine) tumors account for around 80% of uterine cancers, which have a favorable prognosis because the cancer progresses slowly. Uterine cancer has a higher risk of infertility than other types of cancer, giving reason for early detection.

Ovarian Cancer

Ovarian Cancer

routine screening available
routine screening unavailable
screening not very effective
early symptoms
routine screening effective
no early symptoms
some early symptoms
LIFETIME PROBABILITY

1%

avg. stage of diagnosis

2.5

avg. five year survival
  • Stage I: 92%
  • Stage IV: 29% 
  • All stages: 50%
symptoms
  • Bloating
  • Pelvic or abdominal pain
  • Changes in bladder habits
Method of diagnosis
  • Whole-body MRI 
  • Blood test
IMPORTANT FACTS
  • Fifth leading cause of cancer death
  • Can spread quickly within weeks or months
WHY WE SCREEN

Most ovarian cancers develop after menopause, but there are currently no routine screening protocols for women. Ovarian cancer has a high Stage I survival rate of 92%, highlighting the importance of diagnosing the cancer early. A whole-body MRI can identify and track small ovarian cysts over time and monitor if they develop malignant features.